ALIMERA SCIENCES INC 4/A SEC Filings

Filed On	Filing
06 Jan 2022	Form 4/A: Jones John Philip, Chief Financial Officer Holds 16,817 shares of Common Stock
03 Mar 2020	Form 4/A: Ashman Philip, Chief Operating Officer & SVP Holds 8,146 shares of Common Stock
19 Nov 2019	Form 4/A: Jones John Philip, Chief Financial Officer Bought 10,000 shares ($3.01K)
19 Nov 2019	Form 4/A: Eiswirth Richard S Jr, Director Bought 100,000 shares ($29.9K)
17 Sep 2019	Form 4/A: Holland David, Chief Marketing Officer & SVP Holds 263,605 shares of Common Stock
17 Sep 2019	Form 4/A: Holland David, Chief Marketing Officer & SVP Holds 273,588 shares of Common Stock
17 Sep 2019	Form 4/A: Jones John Philip, Chief Financial Officer Holds 105,996 shares of Common Stock
17 Sep 2019	Form 4/A: Jones John Philip, Chief Financial Officer Holds 107,185 shares of Common Stock
17 Sep 2019	Form 4/A: Eiswirth Richard S Jr, Director Holds 358,037 shares of Common Stock
30 Mar 2018	Form 4/A: Holland David, SVP of Sales and Marketing Granted 140,000 Employee Stock Option (Right to Buy)
16 Nov 2015	Form 4/A: Eiswirth Richard S Jr, COO and CFO Received 2,500 shares as a grant or award ($9.27K)
16 Nov 2015	Form 4/A: Holland David, SVP of Sales and Marketing Received 1,834 shares as a grant or award ($6.8K)
16 Nov 2015	Form 4/A: Myers C. Daniel, Director Received 678 shares as a grant or award ($2.51K) · Sold 2,000 shares ($8.74K)
21 Feb 2013	Form 4/A: Kong Garheng, Director Holds 0 Stock Option (Right to Buy)
21 Dec 2012	Form 4/A: Holland David, SVP of Sales & Marketing Gave up 3,630 shares to cover exercise price or tax ($8.28K)
21 Dec 2012	Form 4/A: Caballa Susan, SVP,Regulatory&Medical Affairs Received 10,520 shares as a grant or award
08 Mar 2012	Form 4/A: Largent James R, Director Granted 20,000 Stock Option (Right to Buy)
31 Aug 2011	Form 4/A: Caballa Susan, SEE REMARKS Bought 3,000 shares ($21.5K)
04 May 2011	Form 4/A: Polaris Venture Management Co Iv Llc, 10% owner and 5 others Bought 378,028 shares ($4.16M)

Comments